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Summary and Implications 
 Double stranded RNA was synthesized in vitro with 
sequences corresponding to portions of the IMNV genome 
and were injected into shrimp 2 days after a lethal challenge 
with IMNV. This is the first time these methods have been 
used to treat IMNV infections in shrimp.  
 
Introduction 
 Infectious myonecrosis virus (IMNV) is a non-
enveloped, double stranded RNA (dsRNA), member of the 
Totiviridae family that causes severe disease and economic 
losses in commercially raised shrimp. Currently, there are 
no available vaccines or therapeutics for IMNV. This 
experiment analyzes the effects of IMNV RNAi on 
mortality caused by IMNV.  
 
Materials and Methods 
Specific Pathogen Free (SPF) juvenile L. vannamei 
weighing 5 grams were acquired from Shrimp Improvement 
Systems (SIS) and were acclimated into 200L tanks 
containing synthetic seawater.   Animals were divided into 3 
groups with 3 replicates per group and 10 animals per tank.  
Shrimp were challenged with a lethal dose of IMNV by 
intramuscular injection into the third abdominal segment 
using a previously clarified and diluted tissue homogenate 
positive for IMNV by PCR.  Shrimp were then injected 2 
days later with 5 micrograms of dsRNA81, dsRNAeGFP, or 
an equivalent volume of 2% sterile saline. Mortalities were 
recorded and dead or moribund animals were removed for 
further diagnostic testing (Figure 1).   
 
Results and Discussion 
 After 20 days, significant differences (P<.05) were 
noted between dsRNA81 treated animals and dsRNAeGFP 
or 2% saline controls using ANOVA followed by Tukey’s 
multiple comparison test using JMP 9 software.  No 
significant differences were evident between animals 
injected with dsRNAeGFP or the 2% saline control.  This 
demonstrates that specific dsRNA can therapeutically treat 
IMNV in a sequence dependent manner, and may provide a 
method to treat disease caused by IMNV.   
 
Figure 1.  Survival Curves Following IMNV Challenge 
and Treatment. 
  
 
